Virology and Viral Diseases: How Viruses Infect and Spread

Viruses occupy a strange borderland in biology — not quite alive by classical definitions, yet responsible for some of the most consequential disease events in human history. This page covers how viruses are classified, the step-by-step mechanics of infection, the range of diseases they cause, and how clinicians and researchers decide when a virus crosses from manageable to critical. The science matters far beyond the lab: viral behavior determines vaccine design, outbreak containment strategy, and antiviral drug development.

Definition and scope

A virus is a submicroscopic infectious agent — typically between 20 and 300 nanometers in diameter — that replicates exclusively inside the living cells of an organism. Unlike bacteria, viruses carry no ribosomes, generate no ATP, and cannot reproduce independently. What they do carry is a genome (either DNA or RNA, never both) wrapped in a protein coat called a capsid, sometimes surrounded by a lipid envelope derived from the host cell membrane.

The field studying these agents, virology, covers roughly 6,000 formally described viral species (International Committee on Taxonomy of Viruses, ICTV), though estimates of total viral diversity on Earth run orders of magnitude higher. Viruses infect every domain of life — bacteria (as bacteriophages), archaea, plants, fungi, and animals including humans.

Human-pathogenic viruses are organized into families based on genome type, replication strategy, and structural features. That classification system, maintained by the ICTV, is what allows researchers to make educated guesses about a novel virus's behavior from its genomic signature — an approach central to the bioscience research framework that underpins modern outbreak response.

How it works

Viral infection follows a conserved sequence of steps, regardless of the specific pathogen:

1. Attachment — Viral surface proteins bind to specific receptors on the host cell surface. SARS-CoV-2, for example, uses its spike protein to bind ACE2 receptors found on lung, heart, and kidney cells (NIH National Institute of Allergy and Infectious Diseases).
2. Entry — The virus penetrates the cell membrane, either by fusion (enveloped viruses) or by endocytosis (non-enveloped viruses).
3. Uncoating — The capsid is dismantled, releasing the viral genome into the host cytoplasm or nucleus.
4. Replication — The viral genome hijacks host cellular machinery to replicate itself. RNA viruses typically replicate in the cytoplasm; most DNA viruses replicate in the nucleus.
5. Assembly — New viral proteins and genome copies are assembled into daughter virions.
6. Release — Progeny virions exit via budding (in enveloped viruses, often without killing the cell immediately) or lysis (which destroys the host cell). A single infected cell can release hundreds to thousands of new virions.

The distinction between DNA and RNA viruses matters clinically. RNA viruses mutate at rates roughly 1 million times higher than DNA viruses (Sanjuán et al., Journal of Virology, 2010), because RNA polymerases lack proofreading mechanisms. This error-prone replication is why influenza requires a new vaccine formulation annually, and why HIV evades antiretroviral monotherapy through rapid mutation.

Common scenarios

Viral diseases span an enormous spectrum of severity and transmission mode. Three broad scenarios illustrate the range:

Respiratory transmission drives the highest burden of acute illness globally. Influenza viruses infect an estimated 1 billion people annually worldwide, resulting in 290,000 to 650,000 respiratory deaths per year (World Health Organization). SARS-CoV-2 demonstrated how a novel respiratory virus in the Betacoronavirus genus can generate pandemic conditions when human immune populations carry no prior immunity.

Vector-borne transmission involves an arthropod intermediary — typically a mosquito or tick. Dengue virus, carried by Aedes aegypti and Aedes albopictus mosquitoes, infects an estimated 390 million people per year, of whom roughly 96 million show clinical manifestations (Bhatt et al., Nature, 2013). Dengue's four distinct serotypes (DENV-1 through DENV-4) create an immunological complication: prior infection with one serotype can intensify disease severity upon infection with a second, a phenomenon called antibody-dependent enhancement.

Bloodborne and contact transmission characterizes viruses such as HIV, hepatitis B (HBV), and hepatitis C (HCV). HBV is 50 to 100 times more infectious than HIV per needle-stick exposure (CDC Division of Viral Hepatitis), a fact with direct implications for healthcare worker protocols.

Decision boundaries

Understanding viral biology through the lens explained in how science works as a conceptual process clarifies why certain thresholds matter for public health response.

Three distinctions drive most clinical and policy decisions:

Lytic vs. latent infection — Lytic viruses destroy host cells during replication, causing acute illness. Latent viruses (herpesviruses are the canonical example) integrate into host DNA and persist indefinitely, reactivating under immune stress. Herpes simplex virus type 1 establishes latency in trigeminal ganglia; varicella-zoster virus, after causing chickenpox, can reactivate decades later as shingles.

Enveloped vs. non-enveloped viruses — Lipid envelopes are disrupted by soap, alcohol, and desiccation. Non-enveloped viruses (norovirus, poliovirus) survive on surfaces far longer and resist many common disinfectants — which is why the transmission control strategies differ sharply between the two categories.

Zoonotic potential — Viruses that jump from animal reservoirs to humans (zoonoses) represent the primary source of emerging infectious diseases. Roughly 60 percent of known human infectious diseases are zoonotic in origin (Jones et al., Nature, 2008), and the spillover risk scales with human encroachment on wildlife habitats and live-animal trade density.